Stock 300685 AMOY DIAGNOSTICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Amoy Diagnostics Co., Ltd.

Equities

300685

CNE1000034D3

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
21.55 CNY +2.13% Intraday chart for Amoy Diagnostics Co., Ltd. +2.13% -1.96%
22/04 Amoy Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
15/04 Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Amoy Diagnostics Co., Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on February 26, 2024.
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Amoy Diagnostics to Collaborate with AstraZeneca Unit for Ovarian Cancer Companion Diagnostic in China
Amoy Diagnostics Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date of 23 May 2023
Amoy Diagnostics Co., Ltd. Approves Final Dividend for 2022
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Amoy Diagnostics Co., Ltd. Proposes Final Cash Dividend for the Year 2022
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd. and Precision Medicine Asia Co., Ltd. Announces the Japanese Ministry of Health, Labour and Welfare Approval in Japan as a Companion Diagnostic for Ret Fusion-Positive NSCLC
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Alercell® to Distribute Amoydx® Ros1 Gene Fusion Detection Kit
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Amoy Diagnostics Co., Ltd. Announces Dividend, Payable on May 31, 2022
Amoy Diagnostics Co., Ltd. Approves Dividend for 2021
Amoy Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
AmoyDx conclut un accord-cadre de collaboration avec AstraZeneca pour plusieurs programmes de diagnostics compagnons en Chine, dans l'UE et au Japon
AmoyDx schließt Rahmenkooperationsvereinbarung mit AstraZeneca für mehrere Programme zur begleitenden Diagnostik in China, der EU und Japan ab
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300685 Stock
  4. News Amoy Diagnostics Co., Ltd.
  5. Other languages